Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 309
Filter
1.
Eur J Pediatr ; 182(10): 4323-4328, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37555972

ABSTRACT

Rosacea is a facial inflammatory disorder that shows an increasing incidence with age. While rosacea is common > 60 years of age, pediatric rosacea is uncommon. Diagnostic criteria are based on clinical symptoms. Laboratory investigations and histopathology are only needed to exclude other differential diagnoses. There are several subtypes such as erythemato-telangiectatic, papulo-pustular, periorificial, and granulomatous variants. In contrast to adult rosacea, phymatous subtypes do not belong to pediatric rosacea. A special subtype seen in infants and children is an idiopathic facial aseptic granuloma. Genetic and environmental factors contribute to its pathogenesis. Treatment options are in analogy to adult rosacea classified into topical and systemic drugs. In the case of oral tetracyclines, discoloration of teeth and impairment of enamel are possible adverse events. CONCLUSION: Pediatric rosacea belongs to the rosacea spectrum but has peculiarities compared to the adult subtype. WHAT IS KNOWN: • Rosacea is a chronic inflammatory disorder different from acne. • Rosacea gets more common with advanced age. WHAT IS NEW: • Pediatric rosacea is an uncommon subtype with peculiar clinical presentation. • Demodicosis is very rare in immunocompetent children.


Subject(s)
Rosacea , Infant , Adult , Humans , Child , Rosacea/diagnosis , Rosacea/epidemiology , Rosacea/etiology , Anti-Bacterial Agents/therapeutic use , Granuloma/complications , Granuloma/diagnosis , Granuloma/pathology , Tetracyclines/therapeutic use , Diagnosis, Differential
2.
Int J Dermatol ; 62(5): 599-603, 2023 May.
Article in English | MEDLINE | ID: mdl-35781878

ABSTRACT

Rhinoplasty is considered a very challenging surgery since minimal changes of this central area of the face may significantly impact a person's appearance and self-awareness. This is even more challenging in thick-skinned patients because results are less predictable, and changes to the osseocartilaginous framework (OCF) may not be sufficiently visible due to the blanket effect of the thick skin. Furthermore, pre-existing skin conditions may exacerbate following surgery. Therefore, managing patients with extremely thick skin or patients who suffer from pre-existing dermatological conditions such as rosacea or acne requires a synergy of surgeons and dermatologists to achieve optimal results. In this article, we review the most significant pre- and post-surgical regimens that surgeons and dermatologists should apply in selected patients to achieve optimal results after rhinoplasty.


Subject(s)
Acne Vulgaris , Rhinoplasty , Rosacea , Surgeons , Humans , Rhinoplasty/adverse effects , Skin , Acne Vulgaris/etiology , Rosacea/etiology
3.
Expert Rev Clin Immunol ; 18(12): 1239-1251, 2022 12.
Article in English | MEDLINE | ID: mdl-36137266

ABSTRACT

INTRODUCTION: Recent advances in the understanding of the pathophysiology of rosacea have led to increased focus on the disease's immunologic etiology and to the development of immunologically based treatments. With many patients suffering from incomplete control, addressing the immune components of the disease process may provide a more effective treatment option for rosacea patients that may improve quality of life. AREAS COVERED: This review will provide a brief overview of the pathophysiology of rosacea, as well as specific immunologic contributions to the disease state. Current standard-of-care treatments will be described, including anti-parasitic, anti-inflammatory agents, and antibiotics. Emphasis will be placed on treatments that target the immune components of the disease process. EXPERT OPINION: Rosacea remains a difficult dermatologic disease to treat, partially due to an incomplete understanding of the disease pathophysiology. The immune pathophysiology of rosacea, particularly the key role of inflammation, has been clarified over the past decade. Identification of specific molecules, including cytokines and nuclear transcription factors, may allow for the development of targeted rosacea-specific biologic and topical treatments. However, medication nonadherence is a limiting factor to achieving symptomatic control among rosacea patients. Focusing on the development of oral or injectable forms of therapy may circumvent poor adherence.


Subject(s)
Dermatologic Agents , Rosacea , Humans , Anti-Bacterial Agents/therapeutic use , Quality of Life , Dermatologic Agents/therapeutic use , Rosacea/drug therapy , Rosacea/etiology , Administration, Topical
4.
J Cosmet Dermatol ; 21(7): 2954-2961, 2022 Jul.
Article in English | MEDLINE | ID: mdl-34582097

ABSTRACT

BACKGROUND: Rosacea is a chronic inflammatory skin disease that affects people's life quality. It has been found to be related to many detrimental factors including ultraviolet exposure. However, the association between alcohol consumption and rosacea has long been debated. AIMS: To elucidate this association, we conducted a systematic review and meta-analysis. METHODS: We performed a systematic search of the literature published before February 16, 2021 on PubMed, Embase, and the Cochrane database and used a meta-analytic approach to calculate the pooled odds ratios (ORs) and the corresponding 95% confidence intervals (CIs). RESULTS: Finally, 14 eligible studies were identified, and alcohol consumption was not found to be a risk factor for rosacea. However, in subgroup analysis, alcohol consumption increased the risk of phymatous rosacea (PhR) and the pooled OR was 4.17 (95% CI = 1.76-9.91). CONCLUSION: Overall, our study showed that alcohol consumption was a risk factor in phymatous rosacea (PhR). More studies of rosacea investigating sex distribution, alcohol intake levels, and types of alcoholic beverages consumed are needed in the future.


Subject(s)
Alcohol Drinking , Rosacea , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Humans , Risk Factors , Rosacea/epidemiology , Rosacea/etiology
5.
Clin Exp Dermatol ; 47(2): 325-334, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34426985

ABSTRACT

BACKGROUND: Particulate matter (PM) is a mixture of solid and liquid particles suspended in air, which originates from industrial plants or vehicle emissions. Although the skin is the primary body area of contact with air pollutants, the associations between PM and chronic inflammatory skin diseases has not been well established. AIM: To investigate associations between PM and atopic dermatitis (AD) and between PM and other chronic inflammatory dermatoses, using data from the Korean Health Insurance Review and Assessment Service. METHODS: Monthly disease statistics from the seven largest cities in South Korea (Seoul, Busan, Daegu, Incheon, Gwangju, Daejeon, Ulsan) and from Jeju Island (in total, a population of 23 288 000 for all eight areas) were included. Based on daily air pollution level and weather forecast from 2015 to 2019, multivariate negative binomial regression analysis was conducted to estimate monthly visits of AD with respect to outdoor air pollutants: coarse PM with a diameter of ≤ 10 µm (PM10) and fine PM with a diameter of ≤ 2.5 µm (PM2.5) ozone (O3 ), nitrogen dioxide (NO2 ), sulphur dioxide (SO2 ) and carbon monoxide (CO). RESULTS: Increases in the levels of PM2.5, PM10, SO2 and CO were associated with significant increases in monthly patient visits for AD. Every 10 µg/m3 increase in PM2.5 and PM10 resulted in patient visit increases of 2.71% (95% CI 0.76-4.71; P < 0.01) and 2.01% (95% CI 0.92-3.11, P < 0.001), respectively, while every 1 part per billion (ppb) increase in SO2 and every 100 ppb increase in CO resulted in visit increases of 2.26% (95% CI 1.35-3.17; P < 0.001) and 2.86% (95% CI 1.35-4.40; P < 0.001), respectively. O3 and NO2 were not associated with increased patient visits for AD. Increases in PM2.5 and PM10 concentrations were also significantly associated with increases in patient visits for psoriasis, seborrhoeic dermatitis and rosacea. CONCLUSION: Our data suggest that PM is associated with AD and other chronic inflammatory skin diseases.


Subject(s)
Air Pollutants/adverse effects , Dermatitis, Atopic/etiology , Environmental Exposure/adverse effects , Particulate Matter/adverse effects , Air Pollutants/analysis , Chronic Disease , Dermatitis, Seborrheic/etiology , Humans , Particulate Matter/analysis , Psoriasis/etiology , Republic of Korea , Rosacea/etiology
6.
J Cosmet Dermatol ; 21(7): 3068-3077, 2022 Jul.
Article in English | MEDLINE | ID: mdl-34719110

ABSTRACT

BACKGROUND: No researches about the interaction among the risk factors for rosacea were conducted. Some studies prompted obesity and spicy food may have some common pathways. AIMS: To clarify the relationship between body mass index (BMI) and rosacea, and explore the interaction between BMI and spicy food consumption in rosacea. METHODS: This hospital-based case-control study enrolled 1347 rosacea patients and 1290 healthy subjects. The demographic data and clinical data were collected. The association between BMI and rosacea, and the relative excess risk due to interaction of BMI and spicy food consumption was calculated. RESULTS: No interaction was found between underweight, overweight/obesity, and spicy food consumption with regard to the risk of rosacea, mild-to-moderate rosacea, papulopustular rosacea (PPR), or phymatous rosacea (PhR). And underweight and overweight/obesity were not significant associated with rosacea, mild-to-moderate rosacea, PPR, or PhR (p > 0.05). However, spicy food consumption was significantly interacted with underweight on the risk of erythematotelangiectatic rosacea (ETR), and with overweight/obesity on the risk of severe rosacea. Underweight was associated with increased risk of ETR (adjusted odds ratio [aOR] = 1.91, 95% confidence interval [CI]: 1.21, 3.03) among spicy no users, but the association was attenuated into insignificant level when mixed with spicy food factor (p > 0.05). Among moderated spicy food consumers, overweight/obesity was associated with decreased risk of severe rosacea (aOR = 0.70, 95% CI: 0.50, 0.98), but overweight/obesity was insignificant associated with severe rosacea among spicy no users and heavy spicy food consumers (p > 0.05). CONCLUSIONS: Body weight status alone was not significantly associated with rosacea, but the interaction between body weight status and spicy food consumption is involved in the rosacea.


Subject(s)
Overweight , Rosacea , Body Mass Index , Body Weight , Case-Control Studies , Hospitals , Humans , Obesity/complications , Obesity/epidemiology , Overweight/complications , Overweight/epidemiology , Risk Factors , Rosacea/epidemiology , Rosacea/etiology , Thinness/complications , Thinness/epidemiology
8.
Clin Dermatol ; 40(2): 122-127, 2022.
Article in English | MEDLINE | ID: mdl-34819228

ABSTRACT

Rosacea is a common chronic inflammatory cutaneous disorder, primarily manifesting on the cheeks, nose, chin, and forehead with a classic relapsing-remitting course that affects mostly fair skin types (Fitzpatrick I and II). The pathogenesis remains unclear, but the complex interplay between environmental and genetic factors may augment the innate immune response and neurovascular dysregulation. Different nutrients may play a role in the pathogenesis of rosacea. Many dietary triggers, including hot beverages, alcohol, spicy foods, caffeine, vanilla, cinnamon, niacin, marinated meats, and dairy products, have been postulated for this disease; however, there is a lack of well-designed and controlled studies evaluating the causal relationship between rosacea and dietary factors. We have explored the available evidence and hypotheses based on trigger-food categories of rosacea, the role of the skin-gut microbiome axis, and potentially benefiting dietary factors such as probiotics, prebiotics, and high-fiber diets.


Subject(s)
Gastrointestinal Microbiome , Rosacea , Skin Diseases , Diet/adverse effects , Humans , Rosacea/etiology , Skin
9.
Int J Mol Sci ; 22(21)2021 Nov 07.
Article in English | MEDLINE | ID: mdl-34769465

ABSTRACT

Angiogenesis, the growth of new blood vessels from preexisting vessels, is associated with inflammation in various pathological conditions. Well-known angiogenetic factors include vascular endothelial growth factor (VEGF), angiopoietins, platelet-derived growth factor, transforming growth factor-ß, and basic fibroblast growth factor. Yes-associated protein 1 (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) have recently been added to an important angiogenic factor. Accumulating evidence indicates associations between angiogenesis and chronic inflammatory skin diseases. Angiogenesis is deeply involved in the pathogenesis of psoriasis. VEGF, angiopoietins, tumor necrosis factor-a, interleukin-8, and interleukin-17 are unregulated in psoriasis and induce angiogenesis. Angiogenesis may be involved in the pathogenesis of atopic dermatitis, and in particular, mast cells are a major source of VEGF expression. Angiogenesis is an essential process in rosacea, which is induced by LL-37 from a signal cascade by microorganisms, VEGF, and MMP-3 from mast cells. In addition, angiogenesis by increased VEGF has been reported in chronic urticaria and hidradenitis suppurativa. The finding that VEGF is expressed in inflammatory skin lesions indicates that inhibition of angiogenesis is a useful strategy for treatment of chronic, inflammatory skin disorders.


Subject(s)
Dermatitis/physiopathology , Neovascularization, Pathologic , Angiopoietins/genetics , Angiopoietins/physiology , Animals , Chronic Disease , Dermatitis/complications , Dermatitis/genetics , Dermatitis/pathology , Dermatitis, Atopic/etiology , Dermatitis, Atopic/pathology , Dermatitis, Atopic/physiopathology , Humans , Neovascularization, Pathologic/complications , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/physiopathology , Psoriasis/etiology , Psoriasis/pathology , Psoriasis/physiopathology , Rosacea/etiology , Rosacea/pathology , Rosacea/physiopathology , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/physiology
10.
Clin Dermatol ; 39(4): 695-700, 2021.
Article in English | MEDLINE | ID: mdl-34809774

ABSTRACT

Rosacea is a common inflammatory skin condition with four main clinical subtypes: erythematotelangiectatic, papulopustular, rhinophymatous, and ocular. Although several genetic and environmental factors have been linked with triggering rosacea, the pathogenesis still remains poorly understood. There is an increasing evidence in the literature to support that rosacea is a harbinger of several systemic comorbidities and may represent a chronic, systemic, inflammatory state. We have provided the most up-to-date evidence on the association between rosacea and several systemic diseases, discussing that rosacea is not just a skin disorder but a systemic disease process.


Subject(s)
Cost of Illness , Rosacea , Humans , Rosacea/epidemiology , Rosacea/etiology , Skin
12.
Mol Vis ; 27: 323-353, 2021.
Article in English | MEDLINE | ID: mdl-34035646

ABSTRACT

Rosacea is a chronic inflammatory disease that affects the face skin. It is clinically classified into the following four subgroups depending on its location and severity: erythematotelangiectatic, papulopustular, phymatous, and ocular. Rosacea is a multifactorial disease triggered by favoring factors, the pathogenesis of which remains imperfectly understood. Recognized mechanisms include the innate immune system, with the implication of Toll-like receptors (TLRs) and cathelicidins; neurovascular deregulation involving vascular endothelial growth factor (VEGF), transient receptor potential (TRP) ion channels, and neuropeptides; and dysfunction of skin sebaceous glands and ocular meibomian glands. Microorganisms, genetic predisposition, corticosteroid treatment, and ultraviolet B (UVB) radiation are favoring factors. In this paper, we review the common and specific molecular mechanisms involved in the pathogenesis of cutaneous and ocular rosacea and discuss laboratory and clinical studies, as well as experimental models.


Subject(s)
Eye Diseases/physiopathology , Models, Biological , Rosacea/physiopathology , Skin Diseases/physiopathology , Animals , Disease Models, Animal , Eye Diseases/etiology , Eye Diseases/immunology , Humans , Rosacea/etiology , Rosacea/immunology , Skin Diseases/etiology , Skin Diseases/immunology
13.
J Cosmet Dermatol ; 20(11): 3415-3421, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33626227

ABSTRACT

BACKGROUND: Pathophysiology of rosacea is not completely understood and involves a complex interaction among genetics, ultraviolet (UV) light, microorganisms, impaired skin barrier, neuronal and vascular dysfunction, and immune system disruption. AIMS: To describe the etiology of rosacea with an emphasis on the role of UV radiation and exposome, and to review the importance of non-pharmacologic strategies focusing on photoprotection. METHODS: We conducted a narrative review of the literature. We performed literature searches with PubMed from January 1990 to November 2020 using the keywords "rosacea", "pathogenesis", "ultraviolet radiation", "exposome", "photoprotection", "sunscreens" and "non-pharmacologic agents". The search was limited to English, Spanish, and French language articles. RESULTS: Several environmental factors such as UV light, diverse microorganisms, air pollution, tobacco smoking, nutrition, and psychological stress showed to trigger or worsen rosacea. UV radiation was reported to induce pro-inflammatory, pro-angiogenic, and pro-fibrotic responses. We found 6 original articles about the impact of sunscreens on rosacea. The use of sunscreens containing ingredients with emollient, anti-inflammatory, and/or vasoregulatory properties was shown to significantly improve symptomatology. CONCLUSION: UV radiation and the exposome play a key role in the development of rosacea. UV light is implicated in all significant aspects of rosacea: skin inflammation, neoangiogenesis, telangiectasia, and fibrosis, and may even initiate rosacea. While the use of sunscreens is widely recommended, the literature on the impact of photoprotection in rosacea is scarce. Adequately formulated sunscreens could not only provide the required level of photoprotection, but may also help to mitigate the barrier dysfunction, neutralize facial redness (tinted sunscreens), and decrease inflammation and vascular dysfunction.


Subject(s)
Exposome , Rosacea , Humans , Rosacea/drug therapy , Rosacea/etiology , Rosacea/prevention & control , Skin , Sunscreening Agents/therapeutic use , Ultraviolet Rays/adverse effects
15.
Dermatol Ther ; 34(2): e14747, 2021 03.
Article in English | MEDLINE | ID: mdl-33406295

ABSTRACT

Rosacea is a chronic inflammatory disease of the centrofacial region. However, the association between rosacea and smoking remains controversial. To evaluate the association between rosacea and smoking, we performed a systematic review and meta-analysis. A comprehensive systematic search of literature published before October 15, 2020 on online databases (including Web of Science, PubMed, Cochrane Library, and Embase) was performed. The pooled odds ratios (ORs) were calculated. 12 articles were included, covering 80 156 controls and 54 132 patients with rosacea. Tobacco consumption was not found to increase the risk of rosacea. However, using subtype analysis (involving 5 articles), we found there was a decreased risk of rosacea in current smokers but an increased risk in ex-smokers. In addition, smoking appears to increase the risk of papulopustular rosacea and phymatous rosacea. Analysis of all included studies also showed that ex-smoking was associated with an increased risk, while current smoking was associated with a reduced risk of rosacea. In order to prevent many diseases, including rosacea, the public should be encouraged to avoid smoking.


Subject(s)
Rosacea , Humans , Odds Ratio , Rosacea/epidemiology , Rosacea/etiology , Smoking/adverse effects
16.
J Dermatolog Treat ; 32(1): 114-116, 2021 Feb.
Article in English | MEDLINE | ID: mdl-31132923

ABSTRACT

Background: Dupilumab is used for treatment of atopic dermatitis through blockade of IL-4 and IL-13 signaling of the Th2 pathway. Recent case reports have described alopecia, psoriasis, persistent facial dermatitis, and recall dermatitis at patch test sites after the initiation of dupilumab therapy.Case report: We describe the case of a 67-year-old female with atopic dermatitis who developed recurrent episodic flares of rosacea temporally associated with dupilumab injections that resolved after dupilumab discontinuation.Conclusion: The cause of rosacea-like reaction associated with dupilumab treatment is unknown. Th2 pathway inhibition by dupilumab may promote Demodex proliferation and increased IL-17-mediated inflammation implicated in the pathophysiology of rosacea.Abbreviations: atopic dermatitis: AD; interleukin: IL; persistent facial dermatitis: PFD; T-helper cell type 1: Th1; T-helper cell type 2: Th2; T-helper cell type 17: Th17; tumor necrosis factor-∝: TNF-∝.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Dermatitis, Atopic/drug therapy , Rosacea/diagnosis , Aged , Antibodies, Monoclonal, Humanized/adverse effects , Erythema/etiology , Female , Humans , Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors , Interleukin-4 Receptor alpha Subunit/metabolism , Recurrence , Rosacea/etiology
17.
Clin Exp Dermatol ; 46(3): 430-437, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33217048

ABSTRACT

Rosacea is a chronic inflammatory condition that affects the skin and the eyes. The pathogenesis of rosacea is complex and includes the interaction between genetic and environmental factors, dysregulation of the innate immune system, neurovascular modifications and the interaction with skin commensals. Clinical manifestations in children include the telangiectatic form, papulopustular rosacea, ocular rosacea, periorificial dermatitis, granulomatous rosacea and idiopathic facial aseptic granuloma. Management is aimed at identifying and avoiding triggers. Topical therapy is used for mild cases with topical antibiotics and anti-inflammatory agents. Oral agents are indicated, in combination with topical therapy, for moderate to severe cases. Prolonged therapy may be required.


Subject(s)
Rosacea , Administration, Oral , Administration, Topical , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Child , Dermatologic Agents/therapeutic use , Eye Diseases/diagnosis , Eye Diseases/drug therapy , Eye Diseases/etiology , Eye Diseases/pathology , Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Facial Dermatoses/etiology , Facial Dermatoses/pathology , Granuloma/diagnosis , Granuloma/drug therapy , Granuloma/etiology , Granuloma/pathology , Humans , Rosacea/diagnosis , Rosacea/drug therapy , Rosacea/etiology , Rosacea/pathology
18.
Eur J Ophthalmol ; 31(1): 22-33, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32586107

ABSTRACT

PURPOSE: Rosacea is one of the most common conditions affecting the ocular surface. The purpose of this review is to provide an update on the pathogenesis and treatment of rosacea based on the dermatology and ophthalmology literatures. METHODS: Literature searches were conducted for rosacea and ocular rosacea. Preference was given to systematic reviews, meta-analysis, case-controlled studies, and documented case reports while excluding poorly documented case studies and commentaries. The data were examined and independently analyzed by more than two of the authors. RESULTS: Rosacea is a complex inflammatory condition involving the pilosebaceous unit. Its underlying mechanism involves an interplay of the microbiome, innate immunity, adaptive immunity, environmental triggers, and neurovascular sensitivity. The latest classification of rosacea includes three dermatologic subgroups and a fourth subgroup, ocular rosacea. Ocular rosacea clinically displays many features that are analogous to the cutaneous disease, such as lid margin telangiectasia and phlyctenulosis. The role of environmental triggers in the exacerbation of ocular rosacea appears to be understudied. While lid hygiene and systemic treatment with tetracycline drugs remain the mainstay of treatment for ocular rosacea, newer dermatologic targets and therapies may have potential application for the eye disease. CONCLUSIONS: Ocular rosacea appears to embody many of the manifestation of the dermatologic disease. Hence, the basic pathophysiologic mechanisms of the ocular and cutaneous disease are likely to be shared. Better understanding of the ocular surface microbiome and the immunologic mechanisms, may lead to novel approaches in the management of ocular rosacea.


Subject(s)
Eye Diseases/drug therapy , Eye Diseases/etiology , Rosacea/drug therapy , Rosacea/etiology , Anti-Bacterial Agents/therapeutic use , Antimicrobial Cationic Peptides/therapeutic use , Dermatologic Agents/therapeutic use , Humans , Risk Factors , Tetracycline/therapeutic use , Cathelicidins
19.
Arch Dermatol Res ; 313(4): 225-234, 2021 May.
Article in English | MEDLINE | ID: mdl-32594335

ABSTRACT

Appropriate skincare is essential in the prevention and management of rosacea. We sought to investigate whether cleansing habits, the initial step of skin care, would influence the onset and progression of rosacea and their associations with clinical features of rosacea in the Chinese population. We analyzed the daily cleansing habits data collected from 999 rosacea cases and 1010 skin-healthy controls from China. Overall, the high frequency of cleansing (more than once daily) (OR = 1.450) and the large amount of cleansers (> 5 pieces/year) (OR = 1.612) presented a positive correlation with rosacea occurring. The cleansing duration and types of cleansers appeared not to be correlated with the onset of rosacea in this study. Significant risk factors also included the deep cleansing habits, such as the overuse of cleansing tool (more than four times/week) (OR 2.179) and oil control and exfoliating behaviors via daily used products (OR 2.435), facial mask (OR 1.459) or projects in beauty salons (OR 2.688). The analysis of the clinical features of rosacea showed that patients who prefer deep cleansing were more prone to present an initial symptom of papule and pustule (OR 1.63-3.15). What is more, using daily exfoliating products presented a positive correlation with the progression of the symptoms from flushing to erythema (OR = 2.01), papule and pustule (OR = 2.28) and telangiectasis (OR = 2.14), and the affected areas from a single area to pan facial (OR = 1.650). In conclusion, excessive cleansing habits were substantial risk factors for the incidence and progression of rosacea in the Chinese population.


Subject(s)
Cosmetic Techniques/adverse effects , Cosmetics/adverse effects , Rosacea/epidemiology , Skin Care/adverse effects , Adult , China/epidemiology , Cosmetic Techniques/instrumentation , Cosmetic Techniques/statistics & numerical data , Cosmetics/administration & dosage , Disease Progression , Female , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Risk Factors , Rosacea/diagnosis , Rosacea/etiology , Severity of Illness Index , Skin Care/instrumentation , Skin Care/methods , Skin Care/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...